230 related articles for article (PubMed ID: 20197550)
1. Crystal structure and functional interpretation of the erythrocyte spectrin tetramerization domain complex.
Ipsaro JJ; Harper SL; Messick TE; Marmorstein R; Mondragón A; Speicher DW
Blood; 2010 Jun; 115(23):4843-52. PubMed ID: 20197550
[TBL] [Abstract][Full Text] [Related]
2. The common hereditary elliptocytosis-associated α-spectrin L260P mutation perturbs erythrocyte membranes by stabilizing spectrin in the closed dimer conformation.
Harper SL; Sriswasdi S; Tang HY; Gaetani M; Gallagher PG; Speicher DW
Blood; 2013 Oct; 122(17):3045-53. PubMed ID: 23974198
[TBL] [Abstract][Full Text] [Related]
3. Structural basis for spectrin recognition by ankyrin.
Ipsaro JJ; Mondragón A
Blood; 2010 May; 115(20):4093-101. PubMed ID: 20101027
[TBL] [Abstract][Full Text] [Related]
4. A common type of the spectrin alpha I 46-50a-kD peptide abnormality in hereditary elliptocytosis and pyropoikilocytosis is associated with a mutation distant from the proteolytic cleavage site. Evidence for the functional importance of the triple helical model of spectrin.
Gallagher PG; Tse WT; Coetzer T; Lecomte MC; Garbarz M; Zarkowsky HS; Baruchel A; Ballas SK; Dhermy D; Palek J
J Clin Invest; 1992 Mar; 89(3):892-8. PubMed ID: 1541680
[TBL] [Abstract][Full Text] [Related]
5. Spectrin oligomerization is cooperatively coupled to membrane assembly: a linkage targeted by many hereditary hemolytic anemias?
Giorgi M; Cianci CD; Gallagher PG; Morrow JS
Exp Mol Pathol; 2001 Jun; 70(3):215-30. PubMed ID: 11418000
[TBL] [Abstract][Full Text] [Related]
6. Molecular basis of clinical and morphological heterogeneity in hereditary elliptocytosis (HE) with spectrin alpha I variants.
Lecomte MC; Garbarz M; Gautero H; Bournier O; Galand C; Boivin P; Dhermy D
Br J Haematol; 1993 Nov; 85(3):584-95. PubMed ID: 8136282
[TBL] [Abstract][Full Text] [Related]
7. Structural and functional heterogeneity of alpha spectrin mutations involving the spectrin heterodimer self-association site: relationships to hematologic expression of homozygous hereditary elliptocytosis and hereditary pyropoikilocytosis.
Coetzer T; Palek J; Lawler J; Liu SC; Jarolim P; Lahav M; Prchal JT; Wang W; Alter BP; Schewitz G
Blood; 1990 Jun; 75(11):2235-44. PubMed ID: 2346784
[TBL] [Abstract][Full Text] [Related]
8. Spectrin self-association site: characterization and study of beta-spectrin mutations associated with hereditary elliptocytosis.
Nicolas G; Pedroni S; Fournier C; Gautero H; Craescu C; Dhermy D; Lecomte MC
Biochem J; 1998 May; 332 ( Pt 1)(Pt 1):81-9. PubMed ID: 9576854
[TBL] [Abstract][Full Text] [Related]
9. Nuclear magnetic resonance studies of mutations at the tetramerization region of human alpha spectrin.
Park S; Johnson ME; Fung LW
Blood; 2002 Jul; 100(1):283-8. PubMed ID: 12070038
[TBL] [Abstract][Full Text] [Related]
10. Mutation of a highly conserved isoleucine disrupts hydrophobic interactions in the alpha beta spectrin self-association binding site.
Gallagher PG; Zhang Z; Morrow JS; Forget BG
Lab Invest; 2004 Feb; 84(2):229-34. PubMed ID: 14661034
[TBL] [Abstract][Full Text] [Related]
11. Dynamic molecular modeling of pathogenic mutations in the spectrin self-association domain.
Zhang Z; Weed SA; Gallagher PG; Morrow JS
Blood; 2001 Sep; 98(6):1645-53. PubMed ID: 11535493
[TBL] [Abstract][Full Text] [Related]
12. Molecular determinants of clinical expression of hereditary elliptocytosis and pyropoikilocytosis.
Coetzer T; Lawler J; Prchal JT; Palek J
Blood; 1987 Sep; 70(3):766-72. PubMed ID: 3620700
[TBL] [Abstract][Full Text] [Related]
13. Hereditary pyropoikilocytosis and elliptocytosis in a white French family with the spectrin alpha I/74 variant related to a CGT to CAT codon change (Arg to His) at position 22 of the spectrin alpha I domain.
Garbarz M; Lecomte MC; Féo C; Devaux I; Picat C; Lefebvre C; Galibert F; Gautero H; Bournier O; Galand C
Blood; 1990 Apr; 75(8):1691-8. PubMed ID: 2328319
[TBL] [Abstract][Full Text] [Related]
14. Heterogeneity of the molecular basis of hereditary pyropoikilocytosis and hereditary elliptocytosis associated with increased levels of the spectrin alpha I/74-kilodalton tryptic peptide.
Floyd PB; Gallagher PG; Valentino LA; Davis M; Marchesi SL; Forget BG
Blood; 1991 Sep; 78(5):1364-72. PubMed ID: 1878597
[TBL] [Abstract][Full Text] [Related]
15. Novel exon 2 α spectrin mutation and intragenic crossover: three morphological phenotypes associated with four distinct α spectrin defects.
Swierczek S; Agarwal AM; Naidoo K; Lorenzo FR; Whisenant J; Nussenzveig RH; Agarwal N; Coetzer TL; Prchal JT
Haematologica; 2013 Dec; 98(12):1972-9. PubMed ID: 24077844
[TBL] [Abstract][Full Text] [Related]
16. [Disorders of the membrane skeleton of erythrocytes in hereditary spherocytosis and elliptocytosis: significance of the molecular defect for pathogenesis and clinical severity].
Eber SW
Klin Padiatr; 1991; 203(4):284-95. PubMed ID: 1942935
[TBL] [Abstract][Full Text] [Related]
17. Laboratory method to study mutational effects on human erythrocyte spectrin tetramerization.
Ranganathan S; Menhart N; Topouzian N; Fung LW
Am J Hematol; 2001 Aug; 67(4):247-51. PubMed ID: 11443637
[TBL] [Abstract][Full Text] [Related]
18. Mutational effects at the tetramerization site of nonerythroid alpha spectrin.
Sumandea CA; Fung LW
Brain Res Mol Brain Res; 2005 May; 136(1-2):81-90. PubMed ID: 15893590
[TBL] [Abstract][Full Text] [Related]
19. Association studies of erythroid alpha-spectrin at the tetramerization site.
Lam VQ; Antoniou C; Rolius R; Fung LW
Br J Haematol; 2009 Nov; 147(3):392-5. PubMed ID: 19747366
[TBL] [Abstract][Full Text] [Related]
20. Hereditary elliptocytosis: spectrin and protein 4.1R.
Gallagher PG
Semin Hematol; 2004 Apr; 41(2):142-64. PubMed ID: 15071791
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
